Clinical analysis of paraaortic combined with or not supraclavicular lymph node metastasis in patients with cervical cancer after combined treatment
10.3760/cma.j.issn.1006-9801.2011.05.012
- VernacularTitle:子宫颈癌综合治疗后腹主动脉旁合并或不合并锁骨上淋巴结转移的临床分析
- Author:
Chen QIN
;
Wang MIN
;
Fang YI
- Publication Type:Journal Article
- Keywords:
Uterine cervical neoplasms;
Lymphatic metastasis;
Therapy
- From:
Cancer Research and Clinic
2011;23(5):328-330
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analysis the clinical characteristics, treatment and prognosis for patients with cervical cancer with lymph lode of paraaortic and /or supraclavicular metastasis after combined treatment in two years. Methods Data of 20 patients with lymph lode of paraaortic and /or supraclavicular metastasis of cervical cancer were analyzed retrospectively. Results There was no evidence of lymph node of paraaortic and supraclavicular metastasis before the first combined treatments according to the MRI/CT/SPECT scans in these 20 patients. However, lymph lode of paraaortic and/or supraclavicular metastasis were seen in two years after treatments, the shortest is two months. One patient was progressing during treatment whose pathologic diagnosis is mucinous adenocarcinoma, died in 6 months from treatment start. There was only paraaortic metastasis in 15 patients, among these, 4 patients were found lymph lode of left supraclavical metastasis after retreatments in 3-6 months. Both paraaortic and left-supraclavical lymph node metastasis in 4 cases. Among these 20 cases, recurrence and to give up treatment, whose median survival time is 7.50 months, recurrence and to gain treatment, whose median survival time is 18.98 months, there was significant difference (x2=7.23, P<0.01). Conclusion Patients with cervical cancer with lymph lode of paraaortic and/or supraclavicular metastasis after combined treatment will obviously extend survival time after retretments, which has positive therapy significance.
